uniQure N.V. (QURE)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS

PAASHEUVELWEG 25A AMSTERDAM, NETHERLANDS 1105 BP

uniQure N.V. develops gene therapy products that offer the prospect of long-term and potentially curative benefit to patients with genetic or acquired diseases by directing the expression of a therapeutic protein or restoring the expression of a missing protein through a single administration.

Data based on most recent fiscal year report
Market Cap685.608 Million Shares Outstanding30.8 Million Avg Volume523.828 Thousand
1-Yr BETA vs S&P TR1.701 Current Ratio8.46 Quick Ratio8.46
View SEC Filings from QURE instead.
Q2 2019 All Institutions Hedge Funds 1
To trade QURE now:
Filers who had this stock in their top 10: 12 10 (1.03%)
13F Filers holding this stock: 141 33 (3.41%)
Aggregate 13F shares on 06/30/2019: 26.458 Million 10.527 Million
Aggregate 13F shares on 03/31/2019: 22.711 Million 8.229 Million
Percent change: 16.50% 27.93%
Funds creating new positions: 43 11
Funds Adding to an existing position: 46 11
Funds closing out their position: 28 8
Funds reducing their position: 39 10
1 hedge funds as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding QURE (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

28.8 Thousand total shares from 8 transactions

Exercise Derivative Conversion (M)

8 Thousand total shares from 2 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

KUTA ALEXANDER EDWARD III EXECUTIVE VP, OPERATIONS

  • Officer
41,578 2019-10-15 6

SOTEROPOULOS PAULA CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
678,149 2019-09-26 2

ASTLEY-SPARKE PHILIP EXECUTIVE CHAIRMAN

  • Officer
  • Director
1,427,797 2019-09-23 6

GUT ROBERT CHIEF MEDICAL OFFICER

  • Officer
35,378 2019-09-19 2

KAPUSTA MATTHEW C CEO, CFO, MANAGING DIRECTOR

  • Officer
  • Director
383,652 2019-09-18 8

VAN DEVENTER SANDER EVP, RESEARCH & PRODUCT DEV.

  • Officer
55,213 2019-09-17 3

BALACHANDRAN MADHAVAN

  • Director
12,111 2019-08-22 2

LEWIS WILLIAM CHAIRMAN, PRESIDENT & CEO

  • Officer
  • Director
80,672 2019-06-25 0

KAYE JACK

  • Director
0 2019-06-25 2

MEEK DAVID D.

  • Director
0 2019-06-19 1

KLEMT CHRISTIAN CHIEF ACCOUNTING OFFICER

  • Officer
54,539 2019-04-16 4

SPRINGHORN JEREMY P. CHIEF BUSINESS OFFICER

  • Officer
102,000 2019-02-12 2

SCHAFFER DAVID

  • Director
45,721 2019-01-28 2

MCMILLAN SCOTT T. CHIEF OPERATING OFFICER

  • Officer
20,432 2019-01-28 2

FIRUTA PAUL E CHIEF OPERATING OFFICER

  • Officer
0 2019-01-23 0

ZELENKOFSKE STEVEN CHIEF MEDICAL OFFICER

  • Officer
0 2019-01-23 0

FORUNIQURE B.V.

FORBION 1 MANAGEMENT B.V.

  • 10% Owner
4,376,883 2018-04-23 0

CANTOR MARIA E SVP, INVESTOR REL. & COMM.

  • Officer
92,439 2018-01-26 0

GAREN JONATHAN CHIEF BUSINESS OFFICER

  • Officer
93,638 2018-01-26 0

PETRY HARALD CHIEF SCIENTIFIC OFFICER

  • Officer
0 2017-06-28 0

KESON-BROOKES MAIKEN GENERAL COUNSEL

  • Officer
0 2017-01-27 0

MEYER CHRISTIAN CHIEF MEDICAL OFFICER

  • Officer
0 2017-01-27 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

KUTA ALEXANDER EDWARD III - Officer EXECUTIVE VP, OPERATIONS

2019-10-15 M 4,000 $5.31 a 45,578 41,578.00 direct

KUTA ALEXANDER EDWARD III - Officer EXECUTIVE VP, OPERATIONS

2019-10-15 M 4,000 d 110,000 41,578.00 direct

KUTA ALEXANDER EDWARD III - Officer EXECUTIVE VP, OPERATIONS

2019-10-15 S 4,000 $42.35 d 41,578 41,578.00 direct yes

GUT ROBERT - Officer CHIEF MEDICAL OFFICER

2019-09-19 S 4,769 $47.16 d 35,378 35,378.00 direct

KAPUSTA MATTHEW C - Director - Officer CEO, CFO, MANAGING DIRECTOR

2019-09-18 S 1,841 $47.58 d 383,729 383,652.00 direct yes

KAPUSTA MATTHEW C - Director - Officer CEO, CFO, MANAGING DIRECTOR

2019-09-18 S 3,008 $46.69 d 385,570 383,652.00 direct yes

KAPUSTA MATTHEW C - Director - Officer CEO, CFO, MANAGING DIRECTOR

2019-09-18 S 77 $48.38 d 383,652 383,652.00 direct yes

KAPUSTA MATTHEW C - Director - Officer CEO, CFO, MANAGING DIRECTOR

2019-09-18 S 3,074 $47.73 d 388,578 383,652.00 direct yes

VAN DEVENTER SANDER - Officer EVP, RESEARCH & PRODUCT DEV.

2019-09-17 A 15,000 a 45,354 55,213.00 direct

KUTA ALEXANDER EDWARD III - Officer EXECUTIVE VP, OPERATIONS

2019-09-17 A 15,000 a 41,578 41,578.00 direct

KUTA ALEXANDER EDWARD III - Officer EXECUTIVE VP, OPERATIONS

2019-09-16 S 4,000 $47.26 d 26,578 41,578.00 direct yes

KUTA ALEXANDER EDWARD III - Officer EXECUTIVE VP, OPERATIONS

2019-09-16 M 4,000 d 114,000 41,578.00 direct

KUTA ALEXANDER EDWARD III - Officer EXECUTIVE VP, OPERATIONS

2019-09-16 M 4,000 $5.31 a 30,578 41,578.00 direct

KAPUSTA MATTHEW C - Director - Officer CEO, CFO, MANAGING DIRECTOR

2019-08-21 S 8,000 $56.48 d 391,230 391,230.00 direct yes
Click here to report any possible errors with this stock listing.

Elevate your investments